Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells

上皮-间质转化是 MET 扩增的 EGFR-TKI 耐药非小细胞肺癌细胞对 MET-TKI 序贯治疗的耐药机制